1. Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria. Issue 5 (20th November 2014) Authors: Brownlee, Wallace J; Swanton, Josephine K; Altmann, Daniel R; Ciccarelli, Olga; Miller, David H Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 86:Issue 5(2015) Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Minimal supportive treatment in natalizumab-related PML in a MS patient. Issue 3 (23rd June 2014) Authors: Lalive, Patrice H; Bridel, Claire; Ferfoglia, Ruxandra Iancu; Kaiser, Laurent; Du Pasquier, Renaud; Barkhof, Frederik; Haller, Sven Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 86:Issue 3(2015) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis. Issue 2 (30th April 2014) Authors: Prosperini, Luca; De Angelis, Floriana; De Angelis, Rosanna; Fanelli, Fulvia; Pozzilli, Carlo Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 86:Issue 2(2015) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Transient gadolinium leakage in natalizumab-treated multiple sclerosis. Issue 4 (22nd September 2014) Authors: Haller, Sven; Barkhof, Frederik; Wattjes, Mike P; Lalive, Patrice H Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 86:Issue 4(2015) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗